Latest Insider Transactions at Allakos Inc. (ALLK)
This section provides a real-time view of insider transactions for Allakos Inc. (ALLK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Allakos Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Allakos Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 06
2024
|
Harlan Baird Radford Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,138
-6.89%
|
$13,138
$1.1 P/Share
|
|
Dec 06
2024
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
21,116
-3.81%
|
$21,116
$1.1 P/Share
|
|
Dec 05
2024
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,466
-4.05%
|
$32,466
$1.1 P/Share
|
|
Dec 04
2024
|
Chin Hyok Lee Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,634
-3.72%
|
$10,634
$1.13 P/Share
|
|
Sep 11
2024
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,311
-4.45%
|
$0
$0.58 P/Share
|
|
Sep 09
2024
|
Chin Hyok Lee Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
45,320
-13.69%
|
$0
$0.65 P/Share
|
|
Sep 06
2024
|
Harlan Baird Radford Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,665
-6.69%
|
$0
$0.65 P/Share
|
|
Sep 06
2024
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
21,961
-3.81%
|
$0
$0.65 P/Share
|
|
Jun 28
2024
|
Harlan Baird Radford Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
87,064
-29.87%
|
$87,064
$1.01 P/Share
|
|
Jun 07
2024
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
24,749
-4.14%
|
$24,749
$1.12 P/Share
|
|
Jun 06
2024
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,525
-4.29%
|
$37,525
$1.14 P/Share
|
|
Jun 04
2024
|
Harlan Baird Radford Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,565
-4.76%
|
$14,565
$1.19 P/Share
|
|
Mar 06
2024
|
Harlan Baird Radford Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,142
-9.5%
|
$32,142
$1.35 P/Share
|
|
Mar 05
2024
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
47,392
-7.35%
|
$47,392
$1.44 P/Share
|
|
Mar 04
2024
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
70,910
-7.51%
|
$70,910
$1.48 P/Share
|
|
Dec 04
2023
|
Craig A. Paterson Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,992
-2.12%
|
$13,984
$2.5 P/Share
|
|
Dec 04
2023
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
16,054
-2.44%
|
$32,108
$2.5 P/Share
|
|
Dec 04
2023
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
24,753
-2.56%
|
$49,506
$2.5 P/Share
|
|
Dec 04
2023
|
Harlan Baird Radford Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,380
-2.42%
|
$16,760
$2.5 P/Share
|
|
Sep 05
2023
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,096
-2.83%
|
$84,288
$3.01 P/Share
|
|
Sep 05
2023
|
Harlan Baird Radford Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,511
-2.67%
|
$28,533
$3.01 P/Share
|
|
Sep 05
2023
|
Craig A. Paterson Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,935
-2.34%
|
$23,805
$3.01 P/Share
|
|
Sep 05
2023
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
18,219
-2.69%
|
$54,657
$3.01 P/Share
|
|
Aug 16
2023
|
Alta Partners Management Viii, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
1,463,378
-100.0%
|
-
|
|
Aug 16
2023
|
Alta Partners Management Viii, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
1,463,378
+50.0%
|
-
|
|
Aug 16
2023
|
Alta Partners Management Viii, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
6,448,053
-100.0%
|
-
|
|
Jun 02
2023
|
Craig A. Paterson Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,460
-2.16%
|
$37,300
$5.13 P/Share
|
|
Jun 02
2023
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
17,129
-2.48%
|
$85,645
$5.13 P/Share
|
|
Jun 02
2023
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,415
-2.68%
|
$132,075
$5.13 P/Share
|
|
Jun 02
2023
|
Harlan Baird Radford Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,942
-2.45%
|
$44,710
$5.13 P/Share
|
|
Mar 08
2023
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
66,274
-6.31%
|
$397,644
$6.24 P/Share
|
|
Mar 07
2023
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,143
-0.86%
|
$54,858
$6.4 P/Share
|
|
Mar 06
2023
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
57,467
-7.69%
|
$287,335
$5.34 P/Share
|
|
Mar 03
2023
|
Harlan Baird Radford Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,907
-8.5%
|
$169,535
$5.75 P/Share
|
|
Mar 02
2023
|
Craig A. Paterson Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,615
-7.15%
|
$133,075
$5.83 P/Share
|
|
Jan 06
2023
|
Robert Alexander Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
301,575
+22.2%
|
-
|
|
Jan 06
2023
|
Craig A. Paterson Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
102,690
+21.61%
|
-
|
|
Jan 06
2023
|
Adam Tomasi President |
BUY
Grant, award, or other acquisition
|
Direct |
195,997
+20.83%
|
-
|
|
Jan 06
2023
|
Harlan Baird Radford Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
126,640
+24.1%
|
-
|
|
Dec 02
2022
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,152
-1.97%
|
$121,216
$8.11 P/Share
|
|
Dec 02
2022
|
Craig A. Paterson Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,863
-1.77%
|
$38,904
$8.11 P/Share
|
|
Dec 02
2022
|
Harlan Baird Radford Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,843
-1.39%
|
$30,744
$8.11 P/Share
|
|
Dec 02
2022
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
9,783
-1.75%
|
$78,264
$8.11 P/Share
|
|
Sep 21
2022
|
Paul Edward Walker |
BUY
Open market or private purchase
|
Indirect |
3,984,000
+33.9%
|
$19,920,000
$5.02 P/Share
|
|
Sep 21
2022
|
Daniel Janney Director |
BUY
Open market or private purchase
|
Indirect |
475,000
+15.72%
|
$2,375,000
$5.02 P/Share
|
|
Sep 02
2022
|
Margaret Nell Fitzgerald General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
335
-0.22%
|
$1,340
$4.54 P/Share
|
|
Sep 02
2022
|
Craig A. Paterson Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,129
-0.41%
|
$4,516
$4.54 P/Share
|
|
Sep 02
2022
|
Harlan Baird Radford Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
585
-0.21%
|
$2,340
$4.54 P/Share
|
|
Sep 02
2022
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
5,369
-0.95%
|
$21,476
$4.54 P/Share
|
|
Sep 02
2022
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,316
-1.07%
|
$33,264
$4.54 P/Share
|